Advertisement

Behaviorial Performance Improves After Fetal Substantia Nigra Transplant in Bonnet Monkeys with MPTP Induced Parkinsonism

  • C. R. Freed
  • J. B. Richards
  • M. L. Reite
Chapter
  • 91 Downloads

Abstract

Nearly 10 years have elapsed since the first reports in rats that transplantation of fetal dopamine neurons have an influence on motor behavior in animals with a unilateral lesion of the nigrostriatal tract (Bjorklund and Stenevi, 1979; Perlow et al., 1979). These experiments were important in establishing several basic principles for brain transplantation. First it is a good experimental model. The unilaterally lesioned rat which circles in response to amphetamine or apomorphine as described by Anden et al. (1966) and Ungerstedt (1969) has been useful for studying transplant effects. Second was the discovery that only fetal tissue of a narrow developmental range was useful for transplant. Only the dopamine cells from ventral mesencephalon of fetal rat embryonic day 13 to 15 could successfully reinnervate dopamine denervated striatum. In this animal model, the transplants produced changes in circling behavior within three to six weeks of transplant (Bjorklund and Stenevi, 1979; Perlow et al., 1979; Dunnett et al, 1984). With amphetamine treatment, animals which formerly circled ipsilateral to the side of the dopamine denervation lesion may show a reversal in their circling direction to circle contralateral to the initial lesion. Successful transplants have dopamine cells which survive along the transplant track. In addition, dopamine concentration increases from near total depletion to about 10% of the normal intrinsic dopamine concentration (Schmidt et al., 1984).

Keywords

Parkinsonian Syndrome Crown Rump Length Ventral Mesencephalon Spontaneous Improvement Behavioral Improvement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anden, N.E., Dahlstrom, A., Fuxe, K., and Larsson, K. (1966) Functional role of the nigro-neostriatal dopamine neurons. Acta Pharmacol, et Toxicol. 24:263–274.CrossRefGoogle Scholar
  2. Bakay, R.A.E., Barrow, D.L., Schiff, A., and Fiandanca, M.S. (1985) Biochemical and behavioral corrections of MPTP Parkinson-like syndrome by fetal cell transplantation. Appl. Neurophysiology 48:358–361,1985.Google Scholar
  3. Bankiweicz, K.S., Jacobowitz, D.M., Plunkett, R.J., Oldfield, E.H., and Kopin, I.J. (1987) Injury induced sprouting into the caudate nucleus after solid tissue implantation in MPTP-induced Parkinsonian monkeys. Society for Neuroscience Abstracts, Abstract 46.16.Google Scholar
  4. Björklund, A. and Stenevi, U. (1979) Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177:555–560.PubMedCrossRefGoogle Scholar
  5. Brundin, P., Nilsson, O.G., Gage, F.H., and Björklund, A. (1985) Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons. Exp. Brain Res. 60:204–208.PubMedCrossRefGoogle Scholar
  6. Burns, R.S., Chiueh, C.C., Markey, S.P., Ebert, M.H., Jacobowitz, D.M., and Kopin, I.J. (1983) A primate model of parkinsonism. Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4 phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80:4546–4550.PubMedCrossRefGoogle Scholar
  7. Davis, G.C., Williams, A.C., Markey, S.P., Ebert, M.H., Caine, E.D., Reichert, C.M., and Kopin, I.J. (1979) Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res. 1:249–254.PubMedCrossRefGoogle Scholar
  8. Dubach, M., Schmidt, R., Bowden, D.M., Kunkel, D., Martin, R., and German, D. (1986) Neurons containing tyrosine hydroxylase-like immunoreactivity in the caudate and putamen of a nonhuman primate. Soc. for Neurosci. Abstracts 12:1327, abstract 362.6.Google Scholar
  9. Dunnett, S.B., Björklund, A., Schmidt, R.H., Stenevi, U., and Iversen, S.D (1984) Intracerebral grafting of neronal cell suspensions, V. Behavioral recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites. Acta Physiologica Scandinavica, Suppl. 522: 29–37Google Scholar
  10. Eidelberg, E., Brook, B.A., Morgan, W.W., Walden, J.G., and Kokemoor, R.H. (1986) Variability and functional recovery in the N-methyl-l-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinsonism in monkeys. Neurosci. 18:817–822.CrossRefGoogle Scholar
  11. Freed, C.R., Richards, J.B., Alianiello, E., Peterson, R., Ruppe, L., Singh, S. and Reite, M. (1986) Fetal dopamine cell transplantation as a treatment for Parkinson’s syndrome in bonnet monkeys. Soc. Neurosci. Abstracts 12:1476, abstract 397.6.Google Scholar
  12. Low, W.C., Daniloff, J.K., Bodony, R.P., and Wells, J. (1985) Cross-species transplants of cholinergic neurons and the recovery of function. In Neural Grafting in the Mannalian CNS. (eds. A. Bjorklund and U. Stenevi). Elsevier, Amsterdam.Google Scholar
  13. Perlow, M.J., Freed, W.J., Hoffer, B.J., Seiger, A., Olson, L., and Wyatt, R.J. (1979) Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204:643–647.PubMedCrossRefGoogle Scholar
  14. Redmond, D.E., Jr., Sladek, J.R, Jr., Roth, R.H., Collier, T.J., Elworth, J.D., Deutch, A.Y., and Haber, S. (1986) Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. The Lancet, May 17, No. 8490; 1125–1127.Google Scholar
  15. Schmidt, R.H., Björklund, A., Stenevi, U., Dunnett, S.B., and Gage, F.H. (1984) Intracerebral grafting of neuronal cell suspensions, III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism. Acta Physiologica Scandinavica, Suppl. 522:29–38.Google Scholar
  16. Ungerstedt U., Butcher, L.L., Butcher, S.G., Anden, N.-E., and Fuxe, K. (1969) Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the rat. Brain Res. 14:461–471.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • C. R. Freed
    • 1
  • J. B. Richards
    • 1
  • M. L. Reite
    • 1
  1. 1.Departments of Medicine, Pharmacology, and PsychiatryUniversity of Colorado Health Sciences CenterDenverUSA

Personalised recommendations